Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma.

  • 1 April 1997
    • Vol. 7  (4)
Abstract
No abstract available

This publication has 0 references indexed in Scilit: